SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-23-005628
Filing Date
2023-04-07
Accepted
2023-04-07 16:30:12
Documents
3
Period of Report
2023-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20230518xdef14a.htm DEF 14A 788174
2 GRAPHIC tmb-20230518xdef14a_bg001.jpg GRAPHIC 168083
3 GRAPHIC tmb-20230518xdef14a_bg002.jpg GRAPHIC 142946
  Complete submission text file 0001558370-23-005628.txt   1218060
Mailing Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 206 ENGLEWOOD CO 80112 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: DEF 14A | Act: 34 | File No.: 001-38247 | Film No.: 23809014
SIC: 2834 Pharmaceutical Preparations